Superparamagnetic Reduction/pH/Temperature Multistimuli-Responsive Nanoparticles for Targeted and Controlled...

Area of Science:

• Biomaterials Science
• Nanotechnology
• Polymer Chemistry

Background:

• Developing advanced drug delivery systems is crucial for effective cancer therapy.
• Stimuli-responsive nanoparticles offer targeted drug release, minimizing side effects.
• Biodegradable materials are desirable for minimizing long-term toxicity.

Purpose of the Study:

• To synthesize and characterize multistimuli-responsive polymeric nanoparticles for targeted drug delivery.
• To evaluate the controlled release of doxorubicin hydrochloride (DOX) under various stimuli.
• To assess the biocompatibility and antitumor efficacy of the developed nanoparticles.

Main Methods:

• Core-shell nanoparticles were prepared using superparamagnetic Fe3O4 cores coated with poly(methacrylic acid) (PMAA) and poly(N-isopropylacrylamide) (PNIPAM).
• Two-stage distillation precipitation polymerization was employed for nanoparticle synthesis.
• Drug release studies were conducted at different pH, temperatures, and in the presence of reductive agents (DTT or GSH).
• In vitro biocompatibility and antitumor efficacy were assessed using MTT assay and CLSM analysis.

Main Results:

• The nanoparticles demonstrated triggered release of doxorubicin hydrochloride (DOX), with significant acceleration at pH 5.0 and 10 mM GSH.
• Low drug leakage was observed at physiological pH (7.4) (<11% in 24 h).
• High drug loading capacity and excellent biocompatibility were confirmed.
• DOX-loaded nanoparticles showed promising antitumor efficacy comparable to free DOX.

Conclusions:

• Novel biodegradable, multi-responsive nanoparticles were successfully developed.
• These nanoparticles enable triggered and controlled drug release, ideal for targeted cancer therapy.
• The developed system holds significant potential as a gene/drug delivery vehicle for cancer treatment.